Literature DB >> 31423525

Comment on: Laryngeal mask airway for general anesthesia in interventional neuroradiology procedures.

Abdulaziz Alshaer1.   

Abstract

[No Abstract Available].

Entities:  

Mesh:

Year:  2019        PMID: 31423525      PMCID: PMC6718860          DOI: 10.15537/smj.2019.8.24435

Source DB:  PubMed          Journal:  Saudi Med J        ISSN: 0379-5284            Impact factor:   1.484


To the Editor I have read with interest the article Laryngeal mask airway for general anesthesia in interventional neuroradiology procedures. The objective of the study was to evaluate whether using laryngeal mask airway made a difference in terms of airway security, hemodynamic changes, complications, and recovery times compared to tracheal intubation during the procedure in patients undergoing general anesthesia for endovascular treatments of unruptured cerebrovascular aneurysms.1 If we go into the details of the article, the authors mainly concentrated on the hemodynamic changes pre and post intervention, which was his conclusion, rather than airway security. Therefore, this consider relatively misleading. Second, they did not comment in the intention to treat analysis. In addition, no sample size calculated for the significant conclusion. Lastly, they did not mention the total numbers of patient screened before enrolment, this is important for the applicability of the study in majority or minority only. Reply from the Author No reply was received from the Author.
  1 in total

1.  Laryngeal mask airway for general anesthesia in interventional neuroradiology procedures.

Authors:  Mehmet O Ozhan; Mehmet B Eskin; Bulent Atik; Mehmet A Suzer; Ceyda O Capalar
Journal:  Saudi Med J       Date:  2019-05       Impact factor: 1.484

  1 in total
  1 in total

1.  Application of General Anesthesia Combined with Saphenous Nerve-Tibial Nerve Block in Total Knee Arthroplasty.

Authors:  Hong Li; Kun Wang; Yinlan Qiu; Xia Liu; Xiaoling Ma; Tianhua Li; Qingxiang Cao; Zengjuan Wang
Journal:  Evid Based Complement Alternat Med       Date:  2022-07-19       Impact factor: 2.650

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.